drugset
drugset / Trial / NCT02952547

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

NCT02952547 ↗

Phase 1 Completed 52 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study to Compare the safety and pharmacokinetics between co-administration and fixed dose combination of DWC20155 and DWC20156 in healthy subjects

Timeline

Start
2016-10-30
Primary completion
2016-11-26
Completion
2017-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — Oral
Subject DWC20156 Unknown — Oral
Subject DWJ1366 Unknown — Oral

Indications

No indication recorded.